Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain Tumors

Immunotherapy has revolutionized the care of cancer patients. A diverse set of strategies to overcome cancer immunosuppression and enhance the tumor-directed immune response are in clinical use, but have not achieved transformative benefits for brain tumor patients. Adoptive cell therapies, which em...

Descripción completa

Detalles Bibliográficos
Autores principales: Mount, Christopher W., Gonzalez Castro, Luis Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149956/
https://www.ncbi.nlm.nih.gov/pubmed/35645204
http://dx.doi.org/10.3390/antib11020031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149956/
https://www.ncbi.nlm.nih.gov/pubmed/35645204
http://dx.doi.org/10.3390/antib11020031

Ejemplares similares